Glycolytic reprogramming is involved in tissue remodeling on chronic rhinosinusitis
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0281640 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Min-Sik Jo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Upper Airway Chronic Inflammatory Diseases Laboratory, Korea University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Myofibroblasts, Nasal Polyps. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Background
Glycolytic reprogramming is a key feature of chronic inflammatory disease. Extracellular matrix (ECM) produced by myofibroblasts plays an important role in tissue remodeling of nasal mucosa in chronic rhinosinusitis (CRS). This study aimed to determine whether glycolytic reprogramming contributes to myofibroblast differentiation and ECM production in nasal fibroblasts.
Methods
Primary nasal fibroblasts were isolated from the nasal mucosa of patients with CRS. Glycolytic reprogramming was assessed by measuring the extracellular acidification and oxygen consumption rates in nasal fibroblast, with and without transforming growth factor beta 1 (TGF-β1) treatment. Expression of glycolytic enzymes and ECM components was measured by real-time polymerase chain reaction, western blotting, and immunocytochemical staining. Gene set enrichment analysis was performed using whole RNA-sequencing data of nasal mucosa of healthy donors and patients with CRS.
Result
Glycolysis of nasal fibroblasts stimulated with TGF-B1 was upregulated along with glycolytic enzymes. Hypoxia-inducing factor (HIF)-1α was a high-level regulator of glycolysis, and increased HIF-1α expression promoted glycolysis of nasal fibroblasts, and inhibition of HIF-1α down-regulated myofibroblasts differentiation and ECM production.
Conclusion
This study suggests that inhibition of the glycolytic enzyme and HIF-1α in nasal fibroblasts regulates myofibroblast differentiation and ECM generation associated with nasal mucosa remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Upper Airway Chronic Inflammatory Diseases Laboratory, Korea University College of Medicine, Seoul, South Korea.
- Medical Device Usability Test Center, Guro Hospital, Korea University College of Medicine, Seoul, South Korea.
- Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, South Korea.
ORCID-Profile: Joo-Hoo Park, Jae-Min Shin
Förderung
- Ministry of Science and ICT, South Korea
Zitieren
APA
Jo, M. S., Yang, H. W., Park, J. H., Shin, J. M., & Park, I. H. (2023). Glycolytic reprogramming is involved in tissue remodeling on chronic rhinosinusitis. PLOS ONE. https://doi.org/10.1371/journal.pone.0281640
Vancouver
Jo MS, Yang HW, Park JH, Shin JM, Park IH. Glycolytic reprogramming is involved in tissue remodeling on chronic rhinosinusitis. PLOS ONE. 2023. doi:10.1371/journal.pone.0281640
BibTeX
@article{Jo2023,
author = {Jo, Min-Sik and Yang, Hyun-Woo and Park, Joo-Hoo and Shin, Jae-Min and Park, Il-Ho},
title = {Glycolytic reprogramming is involved in tissue remodeling on chronic rhinosinusitis},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0281640}
}
EUVIMED